Failure of Initial Therapy with Two Nucleosides and Efavirenz is Not Associated with Early Emergence of Mutations in the C-Terminus of HIV-1 Reverse Transcriptase

Documenti analoghi

• Frequent Emergence of N348I in HIV-1 Subtype C Reverse Transcriptase with Failure of Initial Therapy Reduces Susceptibility to Reverse-Transcriptase Inhibitors
  di: Brehm, Jessica H., et al.
  Pubblicazione: (2012)
• Biophysical Insights into the Inhibitory Mechanism of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors
  di: Schauer, Grant, et al.
  Pubblicazione: (2013)
• Bone Mineral Density Effects of Randomized Regimen and Nucleoside Reverse Transcriptase Inhibitor (NRTI) Selection from ACTG A5142
  di: Huang, Jeannie S., et al.
  Pubblicazione: (2013)
• Molecular Mechanism by Which the K70E Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confers Resistance to Nucleoside Reverse Transcriptase Inhibitors
  di: Sluis-Cremer, Nicolas, et al.
  Pubblicazione: (2007)
• Future of nonnucleoside reverse transcriptase inhibitors
  di: Sluis-Cremer, Nicolas
  Pubblicazione: (2018)